+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Toxoplasmosis Drug Pipeline Report 2020 - Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

  • ID: 4849232
  • Drug Pipelines
  • October 2019
  • Region: Global
  • 40 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • GlaxoSmithKline Plc
  • Motif Bio Plc
  • Vaxinano SE
  • Vyera Pharmaceuticals LLC
  • MORE
Toxoplasmosis Drug pipeline report- 2020 is an annual R&D review of Toxoplasmosis pipeline candidates. The report presents the current status of all major Toxoplasmosis therapeutic compounds. Detailed insights into Toxoplasmosis pipeline development, current status, companies, drug profiles and Toxoplasmosis preclinical and clinical trials are included.

2020 Toxoplasmosis Pipeline Market Insights
Toxoplasmosis disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Toxoplasmosis therapies, pipeline by phase and others are included.

Toxoplasmosis Pipeline Drug Profiles
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Toxoplasmosis Therapeutic Drug Candidates
Both active and inactive Toxoplasmosis pipeline drug candidates are included in the report

Toxoplasmosis Clinical Trials and Preclinical Studies
Toxoplasmosis In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Toxoplasmosis Pipeline Market Developments
Toxoplasmosis Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Toxoplasmosis Pipeline Companies in Active Development
The report analyzes Toxoplasmosis pipeline of the below companies-
GlaxoSmithKline Plc, Motif Bio Plc, Vaxinano SE, Vyera Pharmaceuticals LLC

Report Coverage
- What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included
- Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others
- Companies
4 Companies investing in Toxoplasmosis pipeline from discovery stage to pre-registration phase are included
- Drug profiles
Over 10 details of each Toxoplasmosis pipeline candidate are included
- Company Profiles
Business overview and contact details of all companies operating in the industry are provided
- Market Developments
News, Developments and other recent industry developments are included
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • GlaxoSmithKline Plc
  • Motif Bio Plc
  • Vaxinano SE
  • Vyera Pharmaceuticals LLC
  • MORE
1. Toxoplasmosis Pipeline Market Insights, 2020
1.1 Toxoplasmosis Disease Overview
1.2 Toxoplasmosis Drug Pipeline Snapshot, 2020
1.2.1 Toxoplasmosis Pipeline Drugs by Phase
1.2.2 Toxoplasmosis Pipeline Drugs by Company
1.2.3 Toxoplasmosis Pipeline Drugs by Mechanism of Action
1.2.4 Toxoplasmosis Pipeline Drugs by Route of Administration

2. Toxoplasmosis Company wise Pipeline Details
GlaxoSmithKline Plc Toxoplasmosis Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Motif Bio Plc Toxoplasmosis Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Vaxinano SE Toxoplasmosis Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Vyera Pharmaceuticals LLC Toxoplasmosis Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
3. Toxoplasmosis Drug Pipeline Profiles
3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. Toxoplasmosis Pipeline News and Developments

5. Appendix
5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • GlaxoSmithKline Plc
  • Motif Bio Plc
  • Vaxinano SE
  • Vyera Pharmaceuticals LLC
Note: Product cover images may vary from those shown
Adroll
adroll